Skip to content

The Effects of Device-guided Breathing Exercises on Blood Pressure in Patients With Hypertension

The Effects of Device-guided Breathing Exercises on Blood Pressure in Patients With Hypertension. A Randomized, Single-blind, Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00594048
Enrollment
30
Registered
2008-01-15
Start date
2008-01-31
Completion date
2008-05-31
Last updated
2011-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

high blood pressure

Brief summary

The purpose of this study is to determine whether breathing-exercises with the Resperate or listening to a discman with freely chosen music are effective in the treatment of hypertension

Detailed description

Hypertension is an important risk factor for the development of macrovascular events. Lowering blood pressure leads to a reduced risk of developing these complications. To treat hypertension effectively you can use blood pressure lowering drugs, but it is also important to use proven and safe non-pharmacological interventions. It is suggested that Breathing Rate and Systolic Blood Pressure can be linked directly together by the baroreflex. With the use of the Resperate, people will lower their breathing rate by breathing similar to music patterns which could theoretically lead, through the described link, to blood pressure reduction. Patients will be randomize into two groups: one will get a discman with freely chosen music and the other the Resperate. Patients are instructed to use the breathing device or discman for 15 minutes at about the same time every day during the 9 week study period, except for the first week.

Interventions

DEVICEResperate

Use of the device 15 minutes a day for 9 weeks

DEVICEdiscman with freely chosen music

Use the discman 15 minutes a day for 9 weeks

Sponsors

Medical Research Foundation, The Netherlands
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Over 18 years old * Known hypertension with a SBP between 130-170 mmHg at previous visit to the internal outpatient department and at the last visit to the internist * Treated with one or more anti-hypertensive drugs, which have not been changed for the preceding three months * At Baseline the SBP should be between 140-160 mmHg

Exclusion criteria

* Patients with known diabetes * Patients with heart failure (NYHA III-IV) * Patients with pulmonary disease * Patients with insufficient knowledge of the Dutch language to understand the requirements of the study

Design outcomes

Primary

MeasureTime frame
Systolic Blood Pressure9 weeks

Secondary

MeasureTime frame
Quality of life9 weeks
Diastolic Blood Pressure9 weeks

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026